BetaShares Global Healthcare Currency Hedged ETF is a sector & thematic ETF from BetaShares — 66 holdings, with $163.0m under management. 100% of its money is in health care. Its two largest holdings, ELI LILLY & CO and JOHNSON & JOHNSON, make up 16% of the fund. It charges 0.57% a year.
Compare DRUG with another fund →BSX
BOSTON SCIENTIFIC CORP
Health Care · United States · 0.94% of DRUG on average
Contributed −$3 per $10k to DRUG over the last week.
Loading…
Explained moves, and what each did to DRUG
Nothing flagged in this range.
About DRUG
- TypeSector & thematic
- IssuerBetaShares
- Size$163.0m
- Cost0.57% a year
- Holdings66
- Top sectorHealth Care 100%
- Top 2 holdings16%
DRUG rose 0.7% over the last week. On $10,000, that's +$68. ARGX was the biggest drag at −$14; ABBV helped most at +$33.
What moved it
Gain or loss per $10k invested
- ABBVAbbVie+$33
- LLYEli Lilly+$14
- ARGXArgenx−$14
- UNHUnitedHealth+$8
- ISRGIntuitive+$8
- JNJJ&J−$7
- ELVElevance+$6
- DHRDanaher+$6
- RVMDRevolution−$6
- HCAHCA Healthcare+$6
- MRKMerck−$5
- CICigna+$5
- GSKGSK−$5
- BAYNBayer−$5
- ABTAbbott Labs+$5
- AZNAstraZeneca−$5
- SANSanofi−$4
- ROPRoche+$4
- MRNAModerna+$4
- BMYBristol-Myers−$4
- NTRANatera−$4
- 4502Takeda Pharma+$4
- HLNHaleon+$3
- 7741Hoya+$3
- BSXBoston Scientific−$3
- PFEPfizer−$3
- MDTMedtronic+$3
- SYKStryker+$2
- VRTXVertex Pharma−$1
- NOVNNovartis−$1
- GILDGilead−$1
- REGNRegeneron+$1
- AMGNAmgen+$0
- TMOThermo Fisher−$0
- NOVOBNovo Nordisk−$0
- UnattributedHedging, fees, timing+$16
- Fund return+$68
Each kind of news counts the days those moves happened; No flagged news is every other day. News is tracked for moves large enough to be flagged; most international holdings had none in this range.
Which country
- Other 4 countries−$1
- Other 2 countries−$1